menu search

Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
UNIONDALE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical company that has focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, announced that on December 15, 2022, it received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market notifying […] The post Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements appeared first on ForexT... Read More
Posted: Dec 22 2022, 02:50
Author Name: forextv
Views: 110783

Search within

Pages Search Results: